References
- 1. Hong YP, Guo WY, Wang WX, Zhao L, Xiang MW, Mei FC, et al. 4-Phenylbutyric Acid Attenuates Pancreatic Beta-Cell Injury in Rats with Experimental Severe Acute Pancreatitis. Int J Endocrinol. 2016;2016:4592346. DOI: 10.1155/2016/459234610.1155/2016/4592346502148527656209
- 2. Stigliano S, Sternby H, de Madaria E, Capurso G, Petrov MS. Early management of acute pancreatitis: A review of the best evidence. Dig Liver Dis. 2017;49(6):585-94. DOI: 10.1016/j.dld.2017.01.16810.1016/j.dld.2017.01.16828262458
- 3. Abdel-Aziz AM, Rifaai RA, Abdel-Gaber SA. Possible mechanisms mediating the protective effect of cilostazol in L-arginine induced acute pancreatitis in rats: role of cGMP, cAMP, and HO-1. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(10):1859-70. DOI: 10.1007/s00210-020-01897-z10.1007/s00210-020-01897-z32424476
- 4. Miličić D, Jakuš N, Fabijanović D. Microcirculation and heart failure. Curr Pharm Design. 2018;24(25):2954-9. DOI: 10.2174/138161282466618062514323210.2174/138161282466618062514323229938612
- 5. Hirota M, Shimosegawa T, Kitamura K, Takeda K, Takeyama Y, Mayumi T, et al. Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial. J Gastroenterol. 2020;55(3):342-52. DOI: 10.1007/s00535-019-01644-z10.1007/s00535-019-01644-z702621231758329
- 6. Siregar GA, Siregar GP. Management of severe acute pancreatitis. Open Access Maced J Med Sci. 2019;7(19):3319-23. DOI: 10.3889/oamjms.2019.72010.3889/oamjms.2019.720695395031949538
- 7. Wang X, Xu J, Li J, Cheng Y, Liu L, Du Z. Effect of regional arterial infusion combined with early enteral nutrition on severe acute pancreatitis. J Int Med Res. 2019;47(12):6235-43. DOI: 10.1177/030006051988076010.1177/0300060519880760704566331662003
- 8. Fidan S, Erkut M, Cosar AM, Yogun Y, Örem A, Sönmez M, et al. Higher Thrombin-Antithrombin III Complex Levels May Indicate Severe Acute Pancreatitis. Digest Dis. 2018;36(3):244-51. DOI: 10.1159/00048561310.1159/00048561329332096
- 9. Xu C, Liu J, Li Z, Luan X. Efficacy analysis of continuous blood purification therapy for patients with severe acute pancreatitis and acute kidney injury. Panminerva Med. 2020;5(3):61-7. DOI: 10.23736/S0031-0808.20.04032-X10.23736/S0031-0808.20.04032-X32759904
- 10. Gao N, Yan C, Zhang G. Changes of serum procalcitonin (PCT), C-reactive protein (CRP), interleukin-17 (IL-17), interleukin-6 (IL-6), high mobility group protein-B1 (HMGB1) and D-dimer in patients with severe acute pancreatitis treated with continuous renal replacement therapy (CRRT) and its clinical significance. Med Sci Monit. 2018;24:5881-6. DOI: 10.12659/MSM.91009910.12659/MSM.910099611816230136704
- 11. Luo Y, Li Z, Ge P, Guo H, Li L, Zhang G, et al. Comprehensive Mechanism, Novel Markers and Multidisciplinary Treatment of Severe Acute Pancreatitis-Associated Cardiac Injury-A Narrative Review. J Inflamm Res. 2021;14:3145-69. DOI: 10.2147/JIR.S31099010.2147/JIR.S310990
- 12. Rong Y, Ren J, Song W, Xiang R, Ge Y, Lu W, et al. Resveratrol suppresses severe acute pancreatitis-induced microcirculation disturbance through targeting SIRT1-FOXO1 Axis. Oxid Med Cell Longev. 2021;2021: 8891544. DOI: 10.1155/2021/889154410.1155/2021/8891544
- 13. Yang N, Zhang DL, Hao JY. Coagulopathy and the prognostic potential of D-dimer in hyperlipidemia-induced acute pancreatitis. Hepatob Pancreat Dis Int. 2015;14(6):633-41. DOI: 10.1016/S1499-3872(15)60376-910.1016/S1499-3872(15)60376-9
- 14. Zhu Y, Pan X, Zeng H, He W, Xia L, Liu P, et al. A study on the etiology, severity, and mortality of 3260 patients with acute pancreatitis according to the revised Atlanta classification in Jiangxi, China over an 8-year period. Pancreas. 2017;46(4):504-9. DOI: 10.1097/MPA.000000000000077610.1097/MPA.000000000000077628196012